Multidisciplinary approach in the management of hATTR

Ines Losada^{1

2}, Juan González-Moreno^{1

2}, Adrian Rodriguez^{1

2}, Mercedes Uson^{2

3}, Tomas Ripoll-Vera^{2

4}, Asuncion Ferrer-Nadal^{2

3}, Elena Rigo⁵, Hernan Andreu^{2

6}, Antoni Figuerola^{2

3}, Juan Carles Montalà^{2

3}, Cristina Descals^{2

3}, Jorge Álvarez^{2

4}, Francisco Vega-Mañés^{2

5}, Antonia Roig⁷, Eugenia Cisneros-Barroso^{1

2}

Affiliations

¹ Internal Medicine Service, Hospital Universitario Son Llàtzer, Palma, Spain.
² Balearic Research Group in Genetic Cardiopathies, Sudden Death and TTR Amyloidosis, Instituto de Investigación Sanitaria de las Islas Baleares (IdISBa), Palma, Spain.
³ Neurology Service, Hospital Universitario Son Llàtzer, Palma, Spain.
⁴ Cardiology Service, Hospital Universitario Son Llàtzer, Palma, Spain.
⁵ Ophthalmology Service, Hospital Universitario Son Llàtzer, Palma, Spain.
⁶ Hepatology Service, Hospital Universitario Son Llàtzer, Palma, Spain.
⁷ Gynecology and Obstetrics Service, Hospital Universitario Son Llàtzer, Palma, Spain.

PMID: 32474919
DOI: 10.1111/eci.13296

Multidisciplinary approach in the management of hATTR

Ines Losada et al. Eur J Clin Invest. 2020 Oct.

. 2020 Oct;50(10):e13296.

doi: 10.1111/eci.13296. Epub 2020 Aug 11.

Authors

Affiliations

¹ Internal Medicine Service, Hospital Universitario Son Llàtzer, Palma, Spain.
² Balearic Research Group in Genetic Cardiopathies, Sudden Death and TTR Amyloidosis, Instituto de Investigación Sanitaria de las Islas Baleares (IdISBa), Palma, Spain.
³ Neurology Service, Hospital Universitario Son Llàtzer, Palma, Spain.
⁴ Cardiology Service, Hospital Universitario Son Llàtzer, Palma, Spain.
⁵ Ophthalmology Service, Hospital Universitario Son Llàtzer, Palma, Spain.
⁶ Hepatology Service, Hospital Universitario Son Llàtzer, Palma, Spain.
⁷ Gynecology and Obstetrics Service, Hospital Universitario Son Llàtzer, Palma, Spain.

PMID: 32474919
DOI: 10.1111/eci.13296

No abstract available

PubMed Disclaimer

Cited by

Integrated specialty care for amyloidosis: a scoping review using the Consolidated Framework for Implementation Research.
O'Sullivan M, Osman W, Krisnagopal A, Parry M, Davis M, Chu CH. O'Sullivan M, et al. BMC Health Serv Res. 2025 Mar 21;25(1):415. doi: 10.1186/s12913-025-12520-3. BMC Health Serv Res. 2025. PMID: 40114122 Free PMC article.
Val50Met hereditary transthyretin amyloidosis: not just a medical problem, but a psychosocial burden.
González-Moreno J, Gaya-Barroso A, Losada-López I, Rodríguez A, Bosch-Rovira T, Ripoll-Vera T, Usón M, Figuerola A, Descals C, Montalà C, Ferrer-Nadal MA, Cisneros-Barroso E. González-Moreno J, et al. Orphanet J Rare Dis. 2021 Jun 10;16(1):266. doi: 10.1186/s13023-021-01910-5. Orphanet J Rare Dis. 2021. PMID: 34112225 Free PMC article.
Management of Hereditary Transthyretin Amyloidosis (ATTRv) Patients and Asymptomatic Carriers in Spain: The EMPATIa Study.
Losada López I, Gonzalez-Moreno J, Buades Reinés J, Sevilla T, Martinez Valle F, Galán Dávila L, Muñoz Beamud F, Bárcena Llona JE, Romero Acebal M, Tarilonte P, Setaro F. Losada López I, et al. J Clin Med. 2024 Dec 13;13(24):7587. doi: 10.3390/jcm13247587. J Clin Med. 2024. PMID: 39768509 Free PMC article.
Multidisciplinary amyloidosis care in the era of personalized medicine.
Bumma N, Kahwash R, Parikh SV, Isfort M, Freimer M, Vallakati A, Redder E, Campbell CM, Sharma N, Efebera Y, Stino A. Bumma N, et al. Front Neurol. 2022 Oct 13;13:935936. doi: 10.3389/fneur.2022.935936. eCollection 2022. Front Neurol. 2022. PMID: 36341129 Free PMC article. Review.
Clinical and Genotype Characteristics and Symptom Migration in Patients With Mixed Phenotype Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey.
González-Moreno J, Dispenzieri A, Grogan M, Coelho T, Tournev I, Waddington-Cruz M, Wixner J, Diemberger I, Garcia-Pavia P, Chapman D, Gupta P, Glass O, Amass L; THAOS investigators. González-Moreno J, et al. Cardiol Ther. 2024 Mar;13(1):117-135. doi: 10.1007/s40119-023-00344-3. Epub 2023 Dec 20. Cardiol Ther. 2024. PMID: 38117424 Free PMC article.

References

REFERENCES

1. Shin SC, Robinson-Papp J. Amyloid neuropathies. Mt Sinai J Med. 2012;79(6):733-748.
1. Blancas-Mejía LM, Ramirez-Alvarado M. Systemic amyloidoses. Annu Rev Biochem. 2013;82:745-774.
1. Ripoll-Vera T, Buades J, Cisneros E, et al. Cardiac involvement in a patient cohort with Val30Met mutation Transthyretin amyloidosis. Rev Esp Cardiol. 2019;72(1):92-94.
1. Sekijima Y. Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments. J Neurol Neurosurg Psychiatry. 2015;86(9):1036-1043.
1. Coelho T, Maurer MS, Suhr OB. THAOS - the Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis. Curr Med Res Opin. 2013;29(1):63-76.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Supplementary concepts

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Multidisciplinary approach in the management of hATTR

Affiliations

Multidisciplinary approach in the management of hATTR

Authors

Affiliations

Similar articles

Cited by

References

REFERENCES

MeSH terms

Supplementary concepts

LinkOut - more resources

Full Text Sources